Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 101 | TSLX | SIXTH STREET SPECIALTY LENDI | Financial Services | 26,629.0 | $489K | 0.14% | +2K | +6.4% | $18.38 | -2.6% |
| 102 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 23,302.0 | $488K | 0.14% | +4K | +23.5% | $20.95 | +23.2% |
| 103 | — | MSC INCOME FUND INC | — | 39,921.0 | $486K | 0.13% | +3K | +9.3% | $12.18 | — |
| 104 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 32,579.0 | $477K | 0.13% | +796.0 | +2.5% | $14.63 | -6.6% |
| 105 | RZLT | REZOLUTE INC | Healthcare | 151,492.0 | $462K | 0.13% | +4K | +2.5% | $3.05 | +11.5% |
| 106 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 12,049.0 | $461K | 0.13% | +293.0 | +2.5% | $38.30 | -4.7% |
| 107 | CGON | CG ONCOLOGY INC | Healthcare | 6,660.0 | $451K | 0.12% | +163.0 | +2.5% | $67.68 | -1.1% |
| 108 | WHF | WHITEHORSE FIN INC | Financial Services | 60,566.0 | $448K | 0.12% | +3K | +4.7% | $7.40 | -1.2% |
| 109 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 9,034.0 | $443K | 0.12% | +220.0 | +2.5% | $49.05 | +30.3% |
| 110 | ALLO | ALLOGENE THERAPEUTICS INC | Healthcare | 180,588.0 | $441K | 0.12% | +4K | +2.5% | $2.44 | -18.0% |
| 111 | KOD | KODIAK SCIENCES INC | Healthcare | 11,451.0 | $437K | 0.12% | +278.0 | +2.5% | $38.12 | +1.5% |
| 112 | ACLX | ARCELLX INC | Healthcare | 3,794.0 | $436K | 0.12% | +93.0 | +2.5% | $114.82 | +0.2% |
| 113 | NUVB | NUVATION BIO INC | Healthcare | 100,151.0 | $430K | 0.12% | +19K | +23.5% | $4.29 | +10.0% |
| 114 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 13,799.0 | $427K | 0.12% | +337.0 | +2.5% | $30.91 | -3.6% |
| 115 | LENZ | LENZ THERAPEUTICS INC | Healthcare | 46,542.0 | $426K | 0.12% | +9K | +23.5% | $9.15 | -20.3% |
| 116 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 8,110.0 | $409K | 0.11% | +197.0 | +2.5% | $50.44 | +50.0% |
| 117 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 10,286.0 | $409K | 0.11% | +252.0 | +2.5% | $39.72 | -0.3% |
| 118 | MSDL | MORGAN STANLEY DIRECT LENDIN | Financial Services | 28,292.0 | $395K | 0.11% | +2K | +7.7% | $13.96 | +9.0% |
| 119 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 30,230.0 | $388K | 0.11% | +737.0 | +2.5% | $12.82 | +2.1% |
| 120 | ADMA | ADMA BIOLOGICS INC | Healthcare | 42,683.0 | $385K | 0.11% | +8K | +23.5% | $9.01 | -8.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%